The question Nigerian families typically ask when concierge medicine is proposed to them is the same question, asked in a few variations.
Why would we pay a retainer for a doctor when we can just go to a hospital when something is wrong?
It is a fair question, and the answer almost no Nigerian family has been given is that they are already paying — they are just paying the bill in a different currency, on a less visible schedule, with a much larger total at the end. The cost of not having a continuing physician is real. It is paid in money that does not look like medical spending until you total it. It is paid in time. It is paid, eventually, in a diagnosis arriving five years later than it could have.
This piece is for the family that is trying to decide whether the model is worth what it costs. The honest comparison is not concierge medicine against zero medical spending. It is concierge medicine against what your family has, almost certainly, already been spending — in pieces small enough that nobody added them up.
What the family is already paying
Start by adding up what a typical professional family in Lagos, Abuja, or Port Harcourt has actually paid for medical care over the last three years, including the parts they do not file as medical bills. A representative ledger looks like this.
The annual or biannual "executive physical" that the head of household has taken at a private hospital. The price is usually between sixty and three hundred thousand naira per person depending on the panel. The family of four with two adults running it runs somewhere between one hundred and twenty thousand and six hundred thousand naira a year on this line item.
The one or two visits per year to a private hospital out-patient clinic for an acute complaint, where the consultation, the basic investigations, and the prescription run to fifty or eighty thousand naira per visit before the medications.
The specialist referral for a condition the family doctor would have managed if there had been a family doctor. This often runs to three or four visits across one to two months before the question is resolved. The total per episode is frequently somewhere between two hundred and four hundred thousand naira including the imaging or specialist investigations the specialist orders because the specialist has no longitudinal information on the patient.
The medication refill cycle for a family member with hypertension or diabetes, executed at whichever pharmacy is convenient, at whichever brand has stock that week, with no clinician reviewing the dose, the side effects, or the trend in the underlying numbers. The pharmacy spend is small but the cost of uncontrolled chronic disease being treated as if it were controlled is, on the audit data, the largest single hidden category in the family's total medical exposure.
The emergency-department admission. Almost every Nigerian family in this demographic has had at least one of these in the last three years — a parent, a sibling, a child who presented acutely and was admitted for two to seven nights. The admission, depending on the institution and the case, runs from four hundred thousand naira at the lower end to several million at the higher end. A large fraction of these admissions are, on the published clinical audit data, the late presentation of a condition that was clinically active in the patient for months or years before the event, and that a continuing physician would, with high probability, have caught.
The parents abroad — the trip to London, Dubai, or Mumbai for a workup of the chronic complaint the local system has not been able to give a clear answer on. This category is, in the families that engage it, usually the single largest medical expense in the budget. Flights, accommodation, the foreign hospital bills, the time off work, and the family member who travels with the patient adds up to figures most families would prefer not to itemise.
Add these together for a four-year window. The number is almost never below twelve million naira for a family of two adults and two children in this demographic, and is frequently a multiple of that.
This is the spend the family is already making. It is not the question of whether to spend on health. It is the question of what shape the spend takes — and what the shape buys.
What fragmented spending buys, in clinical terms
The argument against fragmented care is not that fragmented care is bad medicine. The individual clinicians providing it are, in the main, competent. The argument is that fragmented care, regardless of the quality of the individual clinicians involved, structurally produces a specific set of clinical failures that a continuing relationship structurally prevents. There are five.
The first is duplicated investigation. The patient with intermittent abdominal pain who sees a different doctor at each visit has, at the end of two years, had three separate ultrasound abdomens, two upper-GI endoscopies, two H. pylori tests, and four basic blood panels, performed by four different practices, with no doctor having seen the previous results before ordering the new ones. The cost of the duplication is real, and the cost is paid by the patient because the practices have no shared record.
The second is the missed trend. The patient whose creatinine has moved from 84 to 96 to 118 across three annual physicals at three different practices has lost forty per cent of his renal function across three years with no clinician reading the trajectory. Each individual value, viewed in isolation, was "within normal limits". The trend, which is what mattered, was visible to nobody.
The third is the late presentation. The patient who has been intermittently aware of a symptom — a lump, a bleeding pattern, a worsening shortness of breath — and who has not had a doctor she felt comfortable raising it with on the small, exploratory consultation that would have resolved or escalated it, presents to the system three or four months later, in the emergency department, with a diagnosis that has progressed from the point at which it could have been managed cheaply to the point at which it is being managed expensively. The cost differential between the two presentations is enormous, and the differential is paid by the family.
The fourth is medication chaos. The patient on antihypertensives whose primary cardiologist, GP, internal-medicine doctor, and ENT have each prescribed or modified medications across the last eighteen months with no central reconciliation arrives at any clinic with a brown bag containing eleven medications, three of which are duplicates of each other under different brand names, two of which interact with each other in a way no individual prescriber has registered, and one of which is the original drug that nobody told him to stop when the replacement was started. This is a clinical hazard in plain sight, and it is also money the family has been spending on medications the patient does not need.
The fifth is the absence of preventive medicine. The patient who is not in a continuing relationship is, in the practice's experience, almost never being screened on the cadence that would catch the conditions that produce the most preventable mortality in this demographic. The HbA1c, the lipid panel with Lipoprotein(a), the ferritin, the coronary calcium score, the ambulatory blood pressure — the tests that catch disease in the asymptomatic window — are not, in the fragmented care model, ordered. They are not ordered because no single clinician owns the patient's preventive trajectory long enough to know what is due.
Each of these five is a category in which the family is spending money, time, or future life that they would not have to spend if a single physician owned the relationship across years.
What a continuing physician actually buys
Once you have the ledger of fragmented spending and the catalogue of fragmented failures in front of you, the question of what concierge medicine — or any genuinely continuing physician relationship — actually buys becomes clearer to answer. The model buys six specific things, and it is worth naming them as six rather than collapsing them into a vague reassurance.
It buys the trend. The same doctor reading the same patient's HbA1c, creatinine, lipid panel, and blood pressure across years, against a baseline he established himself, will identify the inflexion point at which something is moving in the wrong direction at the moment it begins moving, not three years after. The clinical value of catching the inflexion point is, on the cohort data, the single largest contribution preventive medicine makes to long-run outcomes in this demographic.
It buys the relationship in which the patient will tell the doctor the truth. The patient who has been with the same physician for six years tells him she is drinking more than she used to, that her husband has not been well, that she has noticed something in her breast she has been ignoring, that she has been sleeping badly since the business problem started, that she has been taking her mother's blood-pressure pills because hers ran out. The patient who has been to a different doctor each year does not tell anyone any of these things, because the relationship has not been built that they could be said inside.
It buys the medication discipline. A single prescriber who knows the patient's full medication list, the rationale for each entry, and the schedule of review for each is the single highest-leverage intervention in the long-run safety of any patient on more than three chronic medications, which by age fifty includes much of the demographic.
It buys the triage. The patient who has a problem at 8:40 on a Wednesday morning, who can WhatsApp her family physician with a description of it, and who will be told within an hour whether the appropriate next step is to come in, to start a specific medication she has already been prescribed, or to wait twenty-four hours and report back, is not the patient who is going to be in an emergency department at midnight on the same Wednesday on what turns out to have been a manageable problem. The cost differential between the family physician's morning WhatsApp and the emergency-department admission is, by itself, much of the annual cost of the concierge model.
It buys the navigation. When the patient does need a specialist, the family physician who knows the specialist is the difference between the patient seeing the right specialist in the right week and the patient seeing the wrong specialist across two months before someone re-routes him. The Nigerian private health system has, in the better cases, genuinely good specialists. It does not, in the absence of a continuing primary-care physician, have a working referral layer.
It buys the named accountability. When something is going wrong, the patient knows who is responsible for resolving it, and that person knows the patient is theirs to resolve. This is the single most undervalued feature of the model in the Nigerian context, and it is the feature whose absence is the most consistent failure of fragmented care.
The simple math
Take the medical spend the family has been making across the last three years and divide it by three. Compare it to the annual retainer of a continuing concierge practice in Lagos or Abuja. For most of the demographic engaging this question seriously, the retainer is between thirty and seventy per cent of the existing annual spend, and the retainer includes the continuing-care relationship and the preventive panel rather than excluding them.
The retainer is, in other words, not a new expense. It is the rearrangement of the existing expense into a shape that buys continuity, trend-reading, named accountability, and the avoided cost of the late presentation, the duplicated investigation, the medication chaos, and the emergency-department admission that the existing expense has been buying instead.
The family for whom the math does not work this way exists. They are the family with little chronic-disease load, no aging parents in the household, no executive-level professional stress in the system, and a healthy preventive-medicine instinct that they execute consistently on their own. They are a minority of the demographic.
The family for whom the math does work is the family with two or more adults over forty, at least one chronic-disease diagnosis somewhere in the household, an aging parent in the picture, and a fragmented existing relationship with the medical system. For that family — which is most professional Nigerian families in this demographic — the question of cost is not the question of whether to spend more on health. It is the question of whether to keep paying the same money for the shape of care that has been quietly failing them, or to pay it for the shape of care that, on the audit data, doesn't.
The honest close
The piece is not an argument that every Nigerian family needs concierge medicine. It is an argument that every Nigerian family should, before deciding it does not, actually add up the bill it is currently paying — including the parts that do not look like medical bills until you put them in a column. The conversation about whether to enter a continuing relationship with a single physician is a conversation that almost no Nigerian family is having on the basis of the ledger. It is a conversation most families are having on the basis of an instinct that concierge sounds expensive, calibrated against an existing spend the family has never sat down to total.
Total the spend, before you decide. The cost of not having a family doctor is real, and it has been on your account for years. The only question is whether the account has been itemised in a way that lets you see it.